These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2224094)

  • 1. [Aggregates of modified low density lipoproteins indicate accumulation of lipids in human aortic intima cells in vitro].
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Orekhov AN
    Biull Eksp Biol Med; 1990 Jul; 110(7):34-6. PubMed ID: 2224094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low density lipoproteins isolated from the blood of patients with ischemic heart disease induce accumulation of lipids in human aortic intima cells].
    Tertov VV; Kacharava AG; Martseniuk ON; Mukhin DN; Rogova EM; Orekhov AN
    Biull Eksp Biol Med; 1990 Feb; 109(2):117-9. PubMed ID: 2337636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Orekhov AN
    Biochem Biophys Res Commun; 1989 Aug; 163(1):489-94. PubMed ID: 2775281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima.
    Tertov VV; Orekhov AN
    Exp Mol Pathol; 1997; 64(3):127-45. PubMed ID: 9439479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Desialylated low density lipoproteins--atherogenic lipoproteins occurring in blood of patients with coronary atherosclerosis].
    Mukhin DN; Tertov VV; Kacharava AG; Orekhov AN
    Biull Eksp Biol Med; 1990 Aug; 110(8):138-40. PubMed ID: 2291955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation in human aortic intimal cells--the role of lipoprotein aggregation.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Yaroslavov AA; Jauhiainen M; Ehnholm C; Smirnov VN; Orekhov AN
    Eur J Clin Chem Clin Biochem; 1992 Apr; 30(4):171-8. PubMed ID: 1388057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
    Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
    Sobenin IA; Tertov VV; Orekhov AN
    Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation.
    Tertov VV; Orekhov AN; Sobenin IA; Gabbasov ZA; Popov EG; Yaroslavov AA; Smirnov VN
    Circ Res; 1992 Jul; 71(1):218-28. PubMed ID: 1606664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunodetection of modified lipoproteins in plasma and arterial walls of patients with coronary heart disease.
    Sima A; Stancu C; Starodub O; Cristea C; Simionescu M
    Rom J Intern Med; 1997; 35(1-4):29-38. PubMed ID: 9562650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stimulation of cholesterol ester synthesis in macrophages by lipoproteins from normal and atherosclerotic human aorta intima].
    Men'shikov GB; Ivanov VO; Repin VS
    Biokhimiia; 1990 May; 55(5):917-26. PubMed ID: 2393679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells.
    Tertov VV; Orekhov AN; Martsenyuk ON; Perova NV; Smirnov VN
    Exp Mol Pathol; 1989 Jun; 50(3):337-47. PubMed ID: 2721653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages.
    Brown BE; Rashid I; van Reyk DM; Davies MJ
    FEBS J; 2007 Mar; 274(6):1530-41. PubMed ID: 17480204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of a modified low density lipoprotein in humans.
    Avogaro P; Bon GB; Cazzolato G
    Arteriosclerosis; 1988; 8(1):79-87. PubMed ID: 3341993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
    Chono S; Morimoto K
    J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of desialylated low density lipoproteins from the blood of patients with ischemic heart disease by affinity chromatography].
    Tertov VV; Sobenin IA; Tonevitskiĭ AG; Orekhov AN
    Biull Eksp Biol Med; 1990 Dec; 110(12):606-9. PubMed ID: 2083359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingomyelinase-to-LDL molar ratio determines low density lipoprotein aggregation size: biological significance.
    Guarino AJ; Tulenko TN; Wrenn SP
    Chem Phys Lipids; 2006 Jul; 142(1-2):33-42. PubMed ID: 16584719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of cholesterol esterase on low density lipoproteins. The effect of modified lipoproteins on the accumulation of cholesterol in cultured cells].
    Kovaleva GG; Karmanskiĭ IM
    Vopr Med Khim; 1989; 35(3):47-51. PubMed ID: 2773384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
    Orekhov AN; Tertov VV; Mukhin DN
    Atherosclerosis; 1991 Feb; 86(2-3):153-61. PubMed ID: 1872910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.